Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Cash from Investing Activities (2016 - 2025)

Northwest Biotherapeutics' Cash from Investing Activities history spans 16 years, with the latest figure at -$905000.0 for Q4 2025.

  • Quarterly results put Cash from Investing Activities at -$905000.0 for Q4 2025, down 1060.26% from a year ago — trailing twelve months through Dec 2025 was -$1.8 million (down 78.99% YoY), and the annual figure for FY2025 was -$1.8 million, down 78.99%.
  • Cash from Investing Activities for Q4 2025 was -$905000.0 at Northwest Biotherapeutics, down from -$513000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$58000.0 in Q1 2022 to a low of -$2.7 million in Q3 2021.
  • The 5-year median for Cash from Investing Activities is -$427500.0 (2023), against an average of -$759150.0.
  • The sharpest move saw Cash from Investing Activities skyrocketed 89.74% in 2022, then crashed 2198.28% in 2023.
  • Year by year, Cash from Investing Activities stood at -$1.6 million in 2021, then crashed by 39.09% to -$2.2 million in 2022, then skyrocketed by 80.65% to -$418000.0 in 2023, then soared by 81.34% to -$78000.0 in 2024, then plummeted by 1060.26% to -$905000.0 in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$905000.0, -$513000.0, and -$304000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.